XML 44 R30.htm IDEA: XBRL DOCUMENT v3.21.2
STOCKHOLDERS' EQUITY (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 28, 2021
Mar. 02, 2018
Jan. 31, 2020
Apr. 23, 2019
Mar. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares of common stock purchased           8,125,000    
Exercise price           $ 0.18    
Proceeds from the exercise of stock warrants           $ 0 $ 241,911  
Proceeds from Issuance of Private Placement           $ 1,980,000    
Stock Issued During Period, Value, Stock Options Exercised         $ 22,050      
March Warrants [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares of common stock purchased   925,000 1,939,294 1,000,000        
Exercise price               $ 0.125
Proceeds from the exercise of stock warrants   $ 115,625 $ 241,911 $ 125,000        
Private Placement | Securities purchase agreement | Investors                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Aggregate shares sold 0              
Share price $ 0.20              
Gross proceeds $ 1,980,000              
Private Placement | Securities purchase agreement | Series A Warrants | Investors                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares of common stock purchased 7,425,000              
Exercise price $ 0.24              
Term of warrant 2 years              
Private Placement | Securities purchase agreement | Series B Warrants | Investors                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Number of shares of common stock purchased 7,425,000              
Exercise price $ 0.28              
Term of warrant 5 years              
Warrant | Estimate of Fair Value Measurement [Member]                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Exercise price           $ 0.125    
Offering Expenses Related To Warrant Reprice           $ 82,566